The company was chosen for this transformative exercise due to its deep expertise in the healthcare vertical, coupled with its digital engineering and cloud capabilities, a vast partner network, and long-term relationship with the client
Swiftmelt 1515-I meets performance requirements and secures skin attachment
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders
OriCiro's synthetic biology and enzyme technologies will support Moderna's expanding portfolio of therapeutics and vaccines
Collaboration to generate and develop therapeutics for oncology and non-oncology conditions
The objective of this system is to shift the focus of measuring performance of hospitals from volume of services provided to value of healthcare services
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
Moderna and Merck announced mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a 44% reduction in the risk of disease recurrence or death in melanoma patients
The new project further expands the partner's long-term collaboration on new technologies for R&D
Subscribe To Our Newsletter & Stay Updated
